Lecturer in Therapeutics -Part-Time, Clinical Medicine
Publications and Further Research Outputs
Lamorde M, Fillekes Q, Sigaloff K, Kityo C, Buzibye A, Kayiwa J, Merry C, Nakatudde-Katumba L, Burger D, de Wit TF, Therapeutic drug monitoring of nevirapine in saliva in Uganda using high performance liquid chromatography and a low cost thin-layer chromatography technique., BMC infectious diseases, 14, 2014, p473
Scarsi K, Lamorde M, Darin K, Penchala SD, Else L, Nakalema S, Byakika-Kibwika P, Khoo S, Cohn S, Merry C, Back D, Efavirenz- but not nevirapine-based antiretroviral therapy decreases exposure to the levonorgestrel released from a sub-dermal contraceptive implant., Journal of the International AIDS Society, 17, (4 Suppl 3), 2014, p19484
Parkes-Ratanshi R, Elbireer A, Mbambu B, Mayanja F, Coutinho A, Merry C, Ebola outbreak response; experience and development of screening tools for viral haemorrhagic fever (VHF) in a HIV center of excellence near to VHF epicentres., PloS one, 9, (7), 2014, pe100333
Lamorde M, Byakika-Kibwika P, Mayito J, Nabukeera L, Ryan M, Hanpithakpong W, Lefèvre G, Back DJ, Khoo SH, Merry C, Lower artemether, dihydroartemisinin and lumefantrine concentrations during rifampicin-based tuberculosis treatment., AIDS (London, England), 27, (6), 2013, p961-5
Byakika-Kibwika P, Lamorde M, Mayito J, Nabukeera L, Namakula R, Mayanja-Kizza H, Katabira E, Ntale M, Pakker N, Ryan M, Hanpithakpong W, Tarning J, Lindegardh N, de Vries PJ, Khoo S, Back D, Merry C, Significant pharmacokinetic interactions between artemether/lumefantrine and efavirenz or nevirapine in HIV-infected Ugandan adults., The Journal of antimicrobial chemotherapy, 67, (9), 2012, p2213-21
Byakika-Kibwika P, Lamorde M, Mayito J, Nabukeera L, Mayanja-Kizza H, Katabira E, Hanpithakpong W, Obua C, Pakker N, Lindegardh N, Tarning J, de Vries PJ, Merry C, Pharmacokinetics and pharmacodynamics of intravenous artesunate during severe malaria treatment in Ugandan adults., Malaria journal, 11, 2012, p132
Lamorde M, Byakika-Kibwika P, Merry C, Pharmacokinetic interactions between antiretroviral drugs and herbal medicines., British journal of hospital medicine (London, England : 2005), 73, (3), 2012, p132-6
P. Byakika-Kibwika, M. Lamorde, H Mayanja-Kizza, S. Khoo, C. Merry, JP Van geertruyden, Cardiac conduction safety during Artemether-Lumefantrine Combination Therapy for Treatment of Uncomplicated Malaria: The Potential for Complex Interactions with Antiretroviral Drugs in HIV-infected individuals., Chemotherapy Research and Practice, 2011, p5pp
Byakika-Kibwika P, Lamorde M, Lwabi P, Nyakoojo WB, Okaba-Kayom V, Mayanja-Kizza H, Boffito M, Katabira E, Back D, Khoo S, Merry C, Cardiac Conduction Safety during Coadministration of Artemether-Lumefantrine and Lopinavir/Ritonavir in HIV-Infected Ugandan Adults., Chemotherapy research and practice, 2011, 2011, p393976
Mohammed Lamorde, John R.S. Tabuti, Celestino Obua, Collins Kukunda-Byobona, Hindam Lanyero, Pauline Byakika-Kibwika, Godfrey S. Bbosa, Aloysius Lubega, Jasper Ogwal-Okeng, Mairin Ryan, Paul J. Waako and Concepta Merry, Medicinal plants used by traditional medicine practitioners for the treatment of HIV/AIDS and related conditions in Uganda, Journal of Ethnopharmacology, 2010
Lamorde M, Byakika-Kibwika P, Okaba-Kayom V, Flaherty JP, Boffito M, Namakula R, Ryan M, Nakabiito C, Back DJ, Khoo S, Merry C, Scarsi KK, Suboptimal nevirapine steady-state pharmacokinetics during intrapartum compared with postpartum in HIV-1-seropositive Ugandan women., Journal of acquired immune deficiency syndromes (1999), 55, (3), 2010, p345-50
Clinical Pharmacology of Antretroviral Drugs in, editor(s)Ed Sande M, Volberding P& Lange J. , Global HIV/AIDS Medicine, Elsevier, 2008, pp10pp , [Merry, C.]
The contribution of pharmacoeconomics and pharmacology to HIV/AIDS treatment in resource-poor settings in, editor(s)Ed Sande M, Volberding P& Lange J. , Global HIV/AIDS Medicine, Elsevier, 2005, pp171 - 180, [Ryan, M. & Merry, C.]
L. Kyne, C. Merry, B. O'Connell, P. Harrington, C. Keane and D. O'Neill, Simultaneous outbreaks of two strains of toxigenic Clostridium difficile in a general hospital, The Journal of hospital infection, 38, (2), 1998, p101-12
C. Merry, P. Puri and D. J. Reen, Effect of major surgery on neutrophil chemotaxis and actin polymerization in neonates and children, Journal of pediatric surgery, 32, (6), 1997, p813-7
C. Merry, P. Puri and D. J. Reen, Defective neutrophil actin polymerisation and chemotaxis in stressed newborns, Journal of pediatric surgery, 31, (4), 1996, p481-5
DescriptionRole of pharmacology (genomics/kinetics & economics) in optimising outcomes for HIV infected individuals in the resource limited setting. Pharmacokinetics - I have established a HIV pharmacology research laboratory at the University of Makerere, Kampala and am studying the quality of generic drugs; the management of patients who are co-infected with TB and HIV or malaria and HIV; and drug dosing in pregnancy, for children and low-weight adults. I am the principal investigator on a grant from the European Commission's EDCTP for a large project with the University of Cape Town and a co-recipient of funding from the Dutch government for a project between Uganda and Rwanda thereby establishing an expert HIV pharmacology network through south-south and northsouth research collaborations. Pharmacoeconomics, Investigator on study in collaboration with the University of North Carolina evaluating the cost-effectiveness of prevention of mother-to-child transmission in Malawi. I have previously worked in Botswana on a WHO sponsored programme evaluating the cost-effectiveness of public-private partnerships to support the roll-out of antiretroviral drugs I co-ordinated the application from the University of Makerere in collaboration with Johns Hopkins and UCSF to the National Institutes of Health call for a collaborative clinical trial and prevention sites.
Member, DMMC Inflammation, Immunity & Infection Principal Investigators, DMMC Principal Investigators leading research in inflammation, immunit and infection.
Member, Centre for Research into Global Disease (Proposed), This consortium combines researchers with complementary interests in globally significant infectious disease. Interests include innate immunity, immune regulation, regional immunity, immune evasiob, vaccine & adjuvant development as well as drug & target development.
Member of the Scientific Advisory Board of the Academic alliance for HIV/AIDS Care and Prevention
Expert advisor to Nigerian government on HIV care initiatives
Advisor on HIV post-exposure prophylaxis to NGOs, Concern and Suas
Pharmacology advisor to the International AIDS Society
Co-founder/board member of MEREPA a charity based in Ghana to support early childhood development.
Royal College of Physicians of Ireland
Ugandan Medical Council
Irish Medical Council: (15444)
Illinois Department of Professional Regulation